Acessibilidade / Reportar erro

Biotransformation of digitoxigenin by Fusarium ciliatum

Abstracts

The biotransformation of digitoxigenin (1) by Fusarium ciliatum was investigated. The cardenolide 1 was obtained by the acid hydrolysis of digitoxin and the reaction also afforded two side products, identified as delta14-15-digitoxigenin (2) and delta8-14-digitoxigenin (3) by spectroscopic analysis. The biotransformation reaction was carried out in a 5 days process and three products were isolated and had their structures elucidated as digoxigenin (4), digoxigenone (5) and digitoxigenone (6). The investigation of the biotransformation kinetics disclosed 6 as the first derivative to be formed, followed by the more polar hydroxylated products 4 and 5, suggesting the involvement of different enzymes in 12beta hydroxylation and C-3 oxydation of digitoxigenin (1). The production of 5 and 6 under the employed conditions has never been reported. The biotransformation reaction was also undertaken with digitoxin, but F. ciliatum has been unable to promote its hydroxylation.

digitoxigenin; Fusarium ciliatum; digoxigenin; digoxigenone; digitoxigenone


A biotransformação da digitoxigenina (1) por Fusarium ciliatum foi investigada. O cardenolídeo 1 foi obtido a partir da hidrólise ácida da digitoxina e a reação também forneceu os produtos secundários delta14-15-digitoxigenina (2) e delta8-14-digitoxigenina (3). A reação de biotransformação foi realizada em um período de 5 dias e três produtos foram isolados e identificados a partir de análises espectrométricas: digoxigenina (4), digoxigenona (5) e digitoxigenona (6). A obtenção dos dois últimos cardenolídeos nas condições empregadas é inédita. A investigação da cinética da reação de biotransformação indicou 6 como o primeiro produto a ser formado, seguido dos derivados hidroxilados 4 e 5, sugerindo o envolvimento de enzima distintas na hiroxilação em 12beta e na oxidação em C-3 da digitoxigenina (1). A reação de biotransformação também foi realizada com a digitoxina, mas F. ciliatum se mostrou incapaz de promover sua hidroxilação.


ARTICLE

Biotransformation of digitoxigenin by Fusarium ciliatum

Rodrigo M. PáduaI; Alaíde B. OliveiraI; José D. Souza FilhoII; Géssy J. VieiraII; Jacqueline A. Takahashi II; Fernão C. BragaI,* * e-mail: fernao@netuno.lcc.ufmg.br

IFaculdade de Farmácia, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, 31270-010 Belo Horizonte - MG, Brazil

IIDepartamento de Química, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, 31270-010 Belo Horizonte - MG, Brazil

ABSTRACT

The biotransformation of digitoxigenin (1) by Fusarium ciliatum was investigated. The cardenolide 1 was obtained by the acid hydrolysis of digitoxin and the reaction also afforded two side products, identified as D14-15-digitoxigenin (2) and D8-14-digitoxigenin (3) by spectroscopic analysis. The biotransformation reaction was carried out in a 5 days process and three products were isolated and had their structures elucidated as digoxigenin (4), digoxigenone (5) and digitoxigenone (6). The investigation of the biotransformation kinetics disclosed 6 as the first derivative to be formed, followed by the more polar hydroxylated products 4 and 5, suggesting the involvement of different enzymes in 12b hydroxylation and C-3 oxydation of digitoxigenin (1). The production of 5 and 6 under the employed conditions has never been reported. The biotransformation reaction was also undertaken with digitoxin, but F. ciliatum has been unable to promote its hydroxylation.

Keywords: digitoxigenin, Fusarium ciliatum, digoxigenin, digoxigenone, digitoxigenone

RESUMO

A biotransformação da digitoxigenina (1) por Fusarium ciliatum foi investigada. O cardenolídeo 1 foi obtido a partir da hidrólise ácida da digitoxina e a reação também forneceu os produtos secundários D14-15-digitoxigenina (2) e D8-14-digitoxigenina (3). A reação de biotransformação foi realizada em um período de 5 dias e três produtos foram isolados e identificados a partir de análises espectrométricas: digoxigenina (4), digoxigenona (5) e digitoxigenona (6). A obtenção dos dois últimos cardenolídeos nas condições empregadas é inédita. A investigação da cinética da reação de biotransformação indicou 6 como o primeiro produto a ser formado, seguido dos derivados hidroxilados 4 e 5, sugerindo o envolvimento de enzima distintas na hiroxilação em 12b e na oxidação em C-3 da digitoxigenina (1). A reação de biotransformação também foi realizada com a digitoxina, mas F. ciliatum se mostrou incapaz de promover sua hidroxilação.

Introduction

Digoxin (Figure 1), a Digitalis cardenolide, is still the drug of choice for the treatment of congestive heart failure, acting as a selective inhibitor of the Na+,K+ ATPase enzyme. The Digitalis cardenolides are divided into 6 series, based on their genin part, termed A through F. Glycosides of the A series, like lanatoside A, are the most abundant ones, whereas C-type compounds, such as lanatoside C and digoxin, are those clinically used.1


The steroid nucleus of the C glycosides differ from the A glycosides only at the C-12b position, the former bearing a hydroxyl group. Lanatoside C and its derivative digoxin are industrially obtained from the leaves of Digitalis lanata and lanatoside A constitutes a side product. Therefore, it is of interest to find out a process to convert the A-type cardenolides into the corresponding C-type compounds.

Several plant cell cultures have been investigated as a synthetic tool to obtain derivatives of Digitalis cardenolides and the biotransformation of digitoxin into digoxin was successfully accomplished with D. lanata cells in a semi-continuous process.2

Filamentous fungi usually present rates of biomass growth higher than those of plant cell cultures, what turns out fungal transformations more feasible for large scale applications.3 The capacity of Fusarium lini and F. ciliatum to promote digitoxigenin hydroxylation at 12b-position has been demonstrated.4-7 The second species also promoted oxidation of the C-3bOH and digoxigenone was obtained.6F. lini was also investigated for the biotransformation of digitoxin, without success,5 whereas no report was found on the transformation of this substrate by F. ciliatum. Since digitoxin bears a sugar chain at C-3, impairing the oxidation of this position, F. ciliatum seems to be a suitable candidate to transform digitoxin into digoxin. Therefore, the main goal of the present work was to study the biotransformation of digitoxigenin (1) by F. ciliatum and to carry out the reaction with digitoxin aiming at the production of digoxin.

Materials and Methods

General

1H NMR, 13C NMR, 1H 1H COSY and HMQC spectra were recorded on a Bruker DRX-400 spectrometer (1H 400 MHz and 13C 100 MHz) using TMS as internal standard for both nuclei. Chemical shifts (d) are given in ppm and J couplings in Hertz (Hz).

Chemicals

Acetonitrile chromatographic grade LiChrosolv and digitoxin were obtained from Merck (Germany). Water was purified using a Milli-Q50 purification system (Millipore, USA).

Preparation and purification of cardenolides

Digitoxin was purified on a Shimadzu HPLC system (Japan) composed of pump LC-8A, UV-Vis detector SPD-GAV, controller system SCL-8A and integrator C-R4A. An ODS column (250 × 20 mm I.D.) was employed (Shimadzu, Japan) at room temperature, eluted with 84% aqueous CH3CN / H2O (7:3), at a flow rate of 4.8 mL min-1 and UV220 detection. Aliquots of digitoxin (40 mg) were dissolved in MeOH:CHCl3 (9:1; 1 mL) for injection into the apparatus (tR of digitoxin: 24.8 min).

Digitoxigenin (1) was obtained by the acidic hydrolysis of digitoxin (Figure 2). A portion of digitoxin (750 mg) was dissolved in MeOH (250 mL) under sonication, following addition of aqueous 1 mol L-1 HCl (250 mL). The solution was heated at 55ºC, for 35 min, following extraction with CHCl3 (3 × 500 mL). The organic layer was neutralized with 3% NaHCO3 aqueous solution and concentrated until residue (295.7 mg). Portions of the residue (20 mg) were dissolved in MeOH (1 mL) for injection into HPLC equipment. Digitoxigenin (1) and the side products 2 and 3 were separated by preparative RP-HPLC, under the conditions previously described for digitoxin purification (tR of 1: 20.5 min, 236.4 mg, 64% yield; 2: 46.6 min, 16.4 mg, 5% yield; 3: 50.0 min, 6.4 mg, 2% yield).


Biotransformation experiments

Fusarium ciliatum (syn. Calonectria decora) CBS 21554 was obtained from Centralalbureau voor Schimmelcultures (CBS) (Utrecht, Holand). Seven days old cultures, grown in PDA medium, at room temperature, were employed for the experiments.

Erlenmeyer flasks (300 mL) containing 100 mL of sterile medium (composition: 2.0% glucose, 0.5% peptone, 0.3% yeast extract and 0.3% KH2PO4, pH adjusted to 5.7) were inoculated with fresh fungal suspension. Digitoxigenin (1) (10 mg) was dissolved in DMF (1 mL) and added to the flasks, following incubation at room temperature (24-26 ºC), under stirring (200 rpm) for 5 days. The total amount of digitoxigenin (1) submitted to biotransformation was 60 mg. Control experiments containing medium plus substrate (C-1) and medium plus fungus culture (C-2) were carried out in each case. After removing the mycelium by filtration, the biotransformation products were sequentially extracted with chloroform (2 × 100 mL) and chloroform/isopropanol (3:1) (100 mL) in a separator funnel and the solvent was vacuum removed at 50 ºC, until residue. The obtained residues were combined (138.6 mg) and submitted to purification by preparative RP-HPLC, under the conditions described for digitoxigenin purification. Elution was performed with 84% aqueous CH3CN / H2O in different compositions: 37:63 for the isolation of compounds 4 (tR:19.4 min, 10.3 mg, 16% yield) and 5 (tR: 24.9 min, 9.8 mg, 16% yield), and 1:1 for product 6 (tR: 46.9 min, 4.7 mg, 8% yield).

The biotransformation of digitoxin (10 mg/flask) was carried out in the conditions described for digitoxigenin (1). The reaction was stopped after 11 days and the products were immediately extracted as previously described. The biotransformation of digitoxin in the presence of digitoxigenin (8 mg and 2 mg/flask, respectively) was also performed. In one of the experiments, the flasks were submitted to sonication for 30 min, prior to incubation, whereas in the other, 0.15% m/m Tween 80 was added to the reaction medium.

Kinetics of digitoxigenin biotransformation

The biotransformation conditions were those previously described. The reaction was monitored by removing portions (2.7 mL) of the culture medium with a syringe, at regular intervals (36, 60, 84, 108, 132 and 156 h) and the cardenolides were analyzed by RP-HPLC, after appropriate extraction. HPLC analysis were carried out in a Merck-Hitachi apparatus (Germany) composed of intelligent pump L-6200A, autosampler AS-2000A, UV-VIS detector L-4250 and integrator D-2500. An ODS column (250 × 4.0 mm I.D., 5 mm) was employed (Merck, Germany) with temperature of 40 ºC, flow rate of 1.0 mL min-1 and wave length of 220 nm. A gradient elution of H2O (A) and 84% aqueous CH3CN (B) was performed: 0 min 76% A, 24% B; 16.5 min 58% A, 42% B; 22.5 min 52% A, 48% B; 30 min 28% A, 72% B; 35 min 11% A, 89% B. The identification of the components was accomplished by comparing the retention time of the products with those of the isolated cardenolides, injected in the same conditions.

Results and Discussion

Digitoxigenin (1), employed as substrate for biotransformation in the present work, was obtained by the acid hydrolysis of digitoxin under previously described conditions,8 with some modifications (Figure 2). The temperature of the hydrolysis reaction was held at 55 ºC, for 35 min, to minimize the formation of the side product digitoxigenin-monodigitoxoside. After isolation and purification of the obtained digitoxigenin (1) by preparative RP-HPLC, its purity and authenticity was attested by NMR analysis and by data comparison with authentic samples (Table 1).

Besides digitoxigenin (1) (80%), two other products were obtained from the hydrolysis of digitoxin, resulting from dehydration of the hydroxyl group at C-14 (Figure 2). Proton chemical shifts of compound 2 were generally consistent with those of digitoxigenin (1), the major difference being the resonance of an olefinic proton at d 5.23 (J 2.3 Hz, 1H, d) assigned to H-15a. COSY spectroscopy allowed establishing correlations between H-17a and H-16 protons (d 2.45) which, in turn, showed cross peaks with H-15a. Moreover, paramagnetic shifting of C-14 and C-15 signals, observed for digitoxigenin (1) at d 85.5 and d 33.1 to d 154.0 and d 116.5, respectively, allowed the unambiguous assignment of product 2 as D14-15-digitoxigenin.

In a similar way, 13C NMR spectrum of product 3 revealed the signals of two olefinic non-hydrogenated carbons at d 129.7 and d 138.3, respectively assigned to C-8 and C-14, which allowed identifying the other dehydration derivative as D8-14-digitoxigenin (3).V Excepting the diamagnetic shifting observed for H-7a (d 1.90), H-7b (d 2.18) and H-9a (d 2.38), credited to the vicinity of the double bond, all the other chemical shifts were in agreement with those observed for digitoxigenin (1). Hence, these data allowed the unequivocal identification of compound 3 as D8-14-digitoxigenin.

Three compounds were isolated from the biotransformation of digitoxigenin by Fusarium ciliatum (Figure 3). Structure elucidation was accomplished by 1D and 2D NMR techniques, using digitoxigenin (1) as model compound and also by comparison with spectral data reported for other cardenolides.


The 1H NMR spectrum of compound 4 showed a complex profile and the only signals easily assigned were those of H-3 (d 4.14), H-21(d 4.90 and d 4.81) and H-22 (d 5.94), which confirmed the presence of the hydroxyl group at C-3 and the a, b unsaturated lactone ring. Besides, the singlets at d 0.81 and d 0.97 were readily assigned to the methyl groups at C-18 and C-19. The signal at d 3.4 (J 11.0 Hz and 6.4 Hz, 1H, dd) was assigned to a methine hydrogen bearing a hydroxyl group, thus indicating a hydroxylated derivative.

The hydroxylation position was defined on the basis of the chemical shift changes observed for compound 4 in comparison to digitoxigenin (1). Hence, the resonances of C-18 (d 8.9), H-18 (d 0.81) and H-11b (d 1.27) exhibited diamagnetic shifts in comparison to those registered for digitoxigenin (1) (d 15.7, d 0.88 and d 1.46, respectively), allowing to locate the hydroxyl group at the 12b position. These shifts were rationalized as resulting from anisotropic effects of the C-23 carbonyl group and the C-20/22 double bond which, in turn, are the outcome of conformational changes of the steroidal frame or the a,b-unsaturated lactone ring. These data led to the unambiguous identification of 4 as digoxigenin.

Similarly to digoxigenin (4), the 1H NMR spectrum of 5 showed a signal at d 3.47 (J 11.8 Hz and 4.2 Hz, 1H, dd) attributed to a hydroxylated methine group. Likewise 4, the hydroxylation site of compound 5 was deduced from the paramagnetic shifting of the signals from H-18, C-18 and H-11b, which indicated a 12b-hydroxylated derivative. Another feature of the 1H NMR spectrum of 5 was the absence of the characteristic H-3a signal at ca. d 4.10 in the spectra of 1 and 4, which pointed out the oxidation of the C-3bOH. This was confirmed by the chemical shifts observed for H-2a (d 2.53), H-2b (d 2.11), H-4a (d 2.78) and H-4b (d 1.95), within the range expected for a-carbonyl protons,9 as well as by the carbonyl resonance at d 215.7, revealed by the 13C NMR spectrum. Excepting these signals, the other resonances registered for 5 were in agreement with those obtained for digitoxigenin (1) and confirmed the integrity of the cardenolide skeleton. Based on these findings the structure of 5 was assured as digoxigenone.

The carbon-13 and proton chemical shifts observed for compound 6 were generally consistent with those of digitoxigenin (1), excepting the absence of the H-3a resonance signal, likewise 5, which indicated the oxidation of the C-3bOH. This was confirmed by the paramagnetic shifts of the resonances from H-2a (d 2.34), H-2b (d 2.21), H-4a (d 2.62) and H-4b (d 2.13), as a consequence of the vicinity of the C-3 carbonyl. The assignment of C-1 (d 39.8) was accomplished by a HMQC experiment, which disclosed cross peaks with H-1a (d 1.59) and H-1b (d 1.46), whereas the correlation of these hydrogens with H-2b (d 2.34) was revealed by COSY spectroscopy. The oxidation of the C-3bOH was also evidenced by the carbonyl signal at d 212.3 in the 13C NMR spectrum, allowing the unambiguous identification of 6 as digitoxigenone.

The biotransformation of digitoxigenin (1) by F. ciliatum has been previously carried out on a 11 days process and afforded 100% yield of digoxigenone (5).6, 7 In the present work, shortening of the biotransformation reaction time to 5 days afforded the products digoxigenin (4), digoxigenone (5) and digitoxigenone (6) (Figure 3). In order to explain these results, we decided to investigate the biotransformation kinetics of the reaction. Monitoring of the incubation medium by HPLC analysis disclosed digitoxigenone (6) as the first product to be formed (Figure 4), followed by the more polar hydroxylated compounds digoxigenin (4) and digoxigenone (5), that were detected after 24 hours (Figure 5). These data suggest the involvement of different enzymes in the 12b hydroxylation and C-3 oxydation of digitoxigenin (1). After 156 hours, the consumption of the substrate digitoxigenin (1) was almost complete, resulting in the formation of digoxigenin (4). In addition, hydroxylation of the first formed product digitoxigenone (6) occurred in a great extension, leading to the production of digoxigenone (5). Although we did not detect the transformation of compound 4 into 5, in our 5 days process, digoxigenone (5) seems to be the final transformation product of digitoxigenin (1) by F. ciliatum, once it has been previously obtained in a 100% yield, employing a 11 days process.6,7



A triangular hydroxylation model has been proposed for the biotransformation of 5-androstanes by F. ciliatum (syn. Calonectria decora) wherein one of the triangle vertices is the electron rich group and the two others are the sites for hydroxylation.10-13 The 5-androstanes evaluated in those studies possess a hydroxyl or a carbonyl group at C-3 and as a result C-12 and C-15 hydroxylated derivatives were obtained. According to the model, changes on the steroid geometry results in alteration of the hydroxylation sites. In the present work, however, this rule was not strictly followed by digitoxigenin (1), a 5b steroid, since we have obtained the 12b hydroxylated products digoxigenin (4) and digoxigenone (5). On the other hand, no C15-OH derivative nor C-12/C-15 di-hydroxylated product was obtained from digitoxigenin (1). These findings were rationalized as being due to the location of the C-14 hydroxyl group in the cardenolide ring, once the presence of an electron rich group near to the hydroxylation site is known to inhibit the reaction.13 Therefore, both the changes on the steroid geometry and the presence of the hydroxyl group could explain the absence of a C-15 hydroxylated product.

Despite the good results obtained with digitoxigenin (1), F. ciliatum has been unable to promote hydroxylation of digitoxin (Figure 1) under the tested conditions. The 12b hydroxylation of this cardenolide has been previously accomplished with Digitalis cell cultures.14 Our negative result may be attributed to the low solubility of digitoxin in the reaction medium. In order to improve the solubility, we tried the micronization of digitoxin by sonication and the addition of 0.15% m/m Tween 80 to the reaction medium. Both strategies, however, did not result in the recovery of any biotransformation product of digitoxin. These experiments were carried out with mixtures of digitoxin and digitoxigenin (1) in the same flask and resulted in digoxigenin as the only biotransformation product, which allowed us to assure the integrity of the fungus enzymatic system. Another hypothesis to explain the negative result with digitoxin would be the greater permeability of vegetal cell membranes in comparison to fungus cells. The use of chemicals such as cyclodextrines to improve the permeability of digitoxin through the fungus membrane may represent an alternative to overcome this problem and will be assayed in the future.

Conclusions

The present work has demonstrated the viability of converting digitoxigenin (1) into digoxigenin (4) in a 5 days fermentation process with F. ciliatum. The appropriate conditions for the 12b hydroxylation of digitoxin might be further investigated aiming at the production of the therapeutically important digoxin.

Acknowledgements

This research was supported by grant CDS1203/98 from FAPEMIG (Brazil). CNPq (Brazil) is also acknowledged for research fellowships (F.C.B) and for a graduate fellowship (R.M.P.).

Received: June 7, 2004

Published on the web: March 21, 2005

  • 1. Kreis, W.; Hensel, A.; Stuhlemmer, U.; Planta Med. 1998, 64, 491.
  • 2. Kreis, W.; Reinhard, E.; J. Biotechnology 1992, 26, 257.
  • 3. Giri, A.; Dhingra, V.; Giri, C. C.; Singh, A.; Ward, O .P.; Narusu, M. L.; Biotechnology Adv 2001, 19, 175.
  • 4. Tamm, C.; Gluber, A.; Helv. Chim. Acta 1958, 41, 239.
  • 5. Gluber, A.; Tamm, C.; Helv. Chim. Acta 1958, 41, 297
  • 6. Nozaki, Y.; Agricultural Biol. Chem 1961, 25, 461.
  • 7. Nozaki, Y.; Agricultural Biol. Chem 1961, 25, 890.
  • 8. Haussman, W.; Kreis, W.; Stuhlemmer, U.; Reinhard, E.; Planta Med 1997, 63, 446.
  • 9. Bhacca, N. S.; Willians, D. H.; Applications of NMR Spectroscopy in Organic Chemistry: Illustrations from the Steroid Field, Holden-Day: San Francisco, 1969.
  • 10. Bell, A. M.; Denny, W. A.; Jones, R. H.; Meakins, G. D.; J. Chem. Soc., Perkin. Trans. 1 1972, 21, 2059.
  • 11. Bell, A. M.; Cherry, P. C.; Clarck, I. M.; Denny, W. A.; Jones, S. E. R. H.; Meakins, G. D.; Woodgate, P. D.; J. Chem. Soc., Perkin. Trans. 1 1972, 16, 2081.
  • 12. Jones, S. R.H.; Meakins, G. D.; Miners, J. O.; Wilkins, A. L.; J. Chem. Soc., Perkin. Trans. 1 1975, 22, 2308.
  • 13. Holland, H. L.; Chem. Soc. Rev 1982, 11, 371.
  • 14. Kreis, W.; Hoelz, H.; May, U.; Reinhard, E.; Plant Cell, Tissue and Organ Culture 1990, 20, 191.
  • *
    e-mail:
  • Publication Dates

    • Publication in this collection
      09 Aug 2005
    • Date of issue
      June 2005

    History

    • Received
      07 June 2004
    • Accepted
      21 Mar 2005
    Sociedade Brasileira de Química Instituto de Química - UNICAMP, Caixa Postal 6154, 13083-970 Campinas SP - Brazil, Tel./FAX.: +55 19 3521-3151 - São Paulo - SP - Brazil
    E-mail: office@jbcs.sbq.org.br